Ethos Biosciences

Ethos Biosciences, founded in 2018, is a subsidiary of Ott Scientific. The company is committed to designing, developing, and manufacturing precise, reproducible, and easy-to-use assay tools. It advances medical innovation by providing diagnostic tools for scientists and practitioners. In November 2018, Ethos Biosciences acquired the Philadelphia-based Exocell diagnostic business from Glycadia Pharmaceuticals.